Brain Biotech Ag · XETR:BNN

Brain Biotech — Investor Day (February 2023)

10 slides from Brain Biotech's investor day presentation, Feb 27, 2023

  1. Slide 1: BRAIN Biotech AG Capital Markets Day 2023

    BRAIN Biotech AG Creating a #BiobasedFuture Capital Markets Day 2023 Zwingenberg, February 27, 2023 Since 2021 we have been committed to the UN Global Compact corporate responsibility initiative and its principles in the areas of human rights, labor, the environment and anti-corruption. Creating a #

  2. Slide 2: Building the Future in Biotech: Incubator Pipeline Update

    Capital Markets Day 2023 Creating a #BiobasedFuture Building the Future in Biotech: Incubator Pipeline Update Adriaan Moelker, CEO Creating a #BiobasedFuture © BRAIN Biotech AG Zwingenberg Germany www.brain-biotech.com +49 (0) 6251-9331-0 13

  3. Slide 3: BRAIN Incubator

    BRAIN Incubator significant value creation potential rNPV Profit Time-to-Market Current Market Model R&D Potential Options Platform Project BRAIN Incubator Pipeline Partners R&D Market *1 *2 *3 Status 3–5 years out 1–3 years out In pre-launch Fermented Beverages & Ingredients Platform Former NatBev2

  4. Slide 4: Fermented Beverages & Ingredients: Creating a Platform Business

    Fermented Beverages & Ingredients: Creating a Platform Business innovation box: combining the right substrate & microorganism to create healthier food Variety of Selection of Possible end Fermentation Prototyping substrates microorganism(s) products • Vine leaves • Agile collection of more than • Mi

  5. Slide 5: Fermented Beverages & Ingredients: customer solutions from proprietary IP

    Fermented Beverages & Ingredients innovation box: customer solutions from proprietary IP IP BRAIN MS / Go/No- owned Q1/23 Q2/23 Q3/23 Q4/23 Go DP Project I BD: find a partner (EU / US / JP) (fermented natural sweetener – sugar Inaugural Agile Collection & Prototypes replacer in soft drink) Project I

  6. Slide 6: Perillic Active / Fermented Orange Oil – Efficient Natural Antimicrobial

    Perillic Active / Fermented Orange Oil – Efficient Natural Antimicrobial partner model based on proprietary BRAIN technology Key Goals 1. Reducing production costs and Production @ partner CMO investment 2. Outlicensing to new partners Remaining Challenge  Cost in use Existing Partner for distribut

  7. Slide 7: Perillic Active / Fermented Orange Oil – Application Testing in Bread

    Perillic Active / Fermented Orange Oil – Application Testing in Bread our product works well in real applications Dough Breads Application Lab Creating a #BiobasedFuture © BRAIN Biotech AG Zwingenberg Germany www.brain-biotech.com +49 (0) 6251-9331-0 18

  8. Slide 8: Project Schedule Urban Mining

    Project Schedule „Urban Mining< complementary skills and clear path to market Our immediate plans:  Reach communication milestone by end of Q1; Partner announcement  Transfer BioXtractor 2.0 to partner as demo facility for scale-up  Develop „Franchise Model< with partner to market proprietary IP

  9. Slide 9: SolasCure / Aurase – Phase 2a Clinical Trials Progressing Well

    SolasCure / Aurase – Phase 2a Clinical Trials Progressing Well all options evaluated by BRAIN for next stages of clinical development  Phase 2a trials in now complete with full readout expected for Q2  Preliminary results indicate the continued potential of Aurase as a beneficial treatment option

  10. Slide 10: PHA121 – Innovative Oral Treatment for Hereditary Angioedema (HAE)

    PHA121 – Innovative Oral Treatment for Hereditary Angioedema (HAE) clinical development by Pharvaris* Regulatory Update • In August 2022, the U.S. Food & Drug Administration (FDA) placed a hold on the clinical trials of PHA121 in the U.S. based on its review of nonclinical data • The agency requeste

BRAIN Biotech — Investor Day (February 2023) on 6ix